← Company intelligence

Robot maker · registered

eCential Robotics

Corporate marketmedicalCurated record

French surgical-robotics firm (founded 2009 as Surgivisio, rebranded 2021) building the Op.n robotic guidance platform for spine surgery; FDA 510(k)-cleared, 8 systems in Western Europe, 1000+ surgeries. Enovis binding acquisition offer Sep 2026; still operating under own brand.

HeadquartersGières, FR
Founded2009
Corporate funding$110M
TeamNot listed
Deployments2
Open roles0
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageVenture (pre-acquisition)
FoundersStéphane Lavallée (Founder & Chair)
Regions servedNot listed
Countries deployedNot listed
Service footprintNot listed
Last reviewed2026-09-02
XNot listed
DP

Deployment log

Announced and cited only

AnnouncedCustomerSiteCountryCountEvidence
2024-07-25Providence St. Joseph HospitalhospitalUS1Announcement
2021-01-19undisclosed European hospitalshospitalFRNot disclosedAnnouncement
CA

Funding history

Publicly announced rounds

Investors on recordBpifranceSigma GestionMed-InnovEuropean Investment BankCaisse d'Epargne Rhône AlpesCrédit Agricole
TL

Company timeline

Milestones and announcements

2026-09-01Enovis (NYSE: ENOV) enters binding offer to acquire eCential Robotics for €155M (~$172M) upfront plus up to €35M in milestonesPRNewswire
2025-03-01Op.n GEN 1 platform receives FDA 510(k) clearance for spine surgery in the United StatesMassDevice
2021-01-19Raises ~€100M equity/quasi-equity/debt from Bpifrance, Sigma Gestion, Med-Innov and banks; rebrands from Surgivisio to eCential RoboticsInvest in Grenoble Alpes
SC

Source ledger

4 unique public sources